EA
Emerald Advisers’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.8M | Sell |
592,358
-223,547
| -27% | -$4.82M | 0.47% | 83 |
|
|
2025
Q1 | $13.6M | Sell |
815,905
-9,164
| -1% | -$152K | 0.61% | 66 |
|
|
2024
Q4 | $15.1M | Sell |
825,069
-5,760
| -0.7% | -$106K | 0.59% | 69 |
|
|
2024
Q3 | $12.8M | Buy |
830,829
+21,998
| +3% | +$338K | 0.49% | 79 |
|
|
2024
Q2 | $13.1M | Sell |
808,831
-842,293
| -51% | -$13.7M | 0.55% | 67 |
|
|
2024
Q1 | $30.5M | Buy |
1,651,124
+5,559
| +0.3% | +$103K | 1.23% | 21 |
|
|
2023
Q4 | $51.5M | Sell |
1,645,565
-35,487
| -2% | -$1.11M | 2.21% | 2 |
|
|
2023
Q3 | $35M | Buy |
1,681,052
+64,100
| +4% | +$1.34M | 1.7% | 8 |
|
|
2023
Q2 | $38.7M | Buy |
1,616,952
+120,392
| +8% | +$2.88M | 1.69% | 4 |
|
|
2023
Q1 | $28.2M | Buy |
1,496,560
+174,414
| +13% | +$3.28M | 1.35% | 15 |
|
|
2022
Q4 | $21M | Sell |
1,322,146
-7,480
| -0.6% | -$119K | 1.02% | 41 |
|
|
2022
Q3 | $21.8M | Buy |
1,329,626
+468,877
| +54% | +$7.67M | 1.12% | 29 |
|
|
2022
Q2 | $12.1M | Buy |
860,749
+72,011
| +9% | +$1.01M | 0.62% | 67 |
|
|
2022
Q1 | $19.1M | Buy |
788,738
+71,420
| +10% | +$1.73M | 0.73% | 60 |
|
|
2021
Q4 | $16.7M | Buy |
+717,318
| New | +$16.7M | 0.62% | 68 |
|